Bispecific Antibody Market Growing Incidence of B-Cell Lymphoma

According to Precision Business Insights (PBI), latest report, the global bispecific antibody market was valued at USD 1,715.9 million in 2022 and is expected to grow at CAGR of 11.3% during the forecast period 2023 to 2029. The primary drivers of the expansion of the bispecific antibody market include the increasing prevalence of cancer across the globe. In addition, ongoing research and development activities are expected to boost the growth of bispecific antibody market over the forecast period.

View the detailed report description here - https://www.precisionbusinessinsights.com/market-reports/bispecific-antibody-market

The bispecific antibody market is segmented based on drug type, indication, distribution channel, and geography.
Based on the drug type, the market is segmented into the following:
• Blinatumomab
• Catumaxomab
• Duligotumab
• Others
Based on the indication, the market is segmented into the following:
• Cancer
• Infectious Disease
• Inflammatory & Autoimmune Disorders
• CNS Disorders
• Others
Based on the distribution channel, the market is segmented into the following:
• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

Based on geography, the market is segmented into the following:
• North America
• Europe
• The Asia Pacific
• Latin America
• MEA

Cancer Segment is expected to Dominate the Bispecific Antibody Market:
Based on the indication, the global Bispecific Antibody market is segmented into cancer, infectious disease, inflammatory & autoimmune disorders, CNS disorders, and others. The cancer segment is expected to account for a larger revenue share in the global bispecific antibody market. The increasing prevalence of cancer across the globe, resulting in the growing demand for personalized medicines and targeted therapy. The bispecific antibody has shown a significant positive outcome when compared to chemotherapy. In addition, many researchers are in a study to discover a more efficient treatment for cancer which resulted in innovation of new novel therapies and is expected to drive the bispecific market in this segment.

North America Bispecific Antibody Market:
The North America bispecific antibody market is expected to increase over the forecast period due to the presence of major players in this region. In addition, increasing demand for novel therapeutics for the treatment of cancer in this region is expected to boost the market growth. Furthermore, increasing investments by pharmaceutical companies and in research and development along with the ongoing clinical trials of new bispecific antibodies in this region are anticipated to fuel the growth of market. Moreover, the favourable government policies and regulations in this region is expected to aid the market growth over the forecast period.

Request Sample: https://www.precisionbusinessinsights.com/request-sample/?product_id=38314

Strategic New Product Launches, Mergers, Acquisitions, and Agreements are the key strategies adopted by market players.
The global Bispecific Antibody market further reveals that the key players are increasingly adopting strategies such as the launch of newer products, product launches, and long-term alliances to improve market revenue share and gain significant geographic presence across the region.

Key players profiles in the Bispecific Antibody Market report are AbbVie, Celgene Corporation, Bristol Myers Squibb, Macro Genic, Calico, TG Therapeutics, Eli Lilly Corporation, Regeneron Pharmaceuticals Inc, Hoffmann-La Roche Ltd, Sanofi SA.

Contact:
Mr. Satya
Precision Business Insights | Toll-Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 - 160 City Road, London EC1V 2NX
Website: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet particular research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

This release was published on openPR.